AI isn’t close to curing cancer. Vivodyne says it knows what it will take; plus, TerraPower’s nuclear reactor has a secret weapon for powering AI data centers

A handful of AI-designed drugs have proceeded into human trials — one as far as Phase III, widespread human testing — but the reality is that the roadblocks aren’t necessarily ones that AI can solve today. Also, TerraPower's nuclear power plant possesses a strategic advantage over competitors, especially when chasing after data center deals. Learn more about your ad choices. Visit podcastchoices.com/adchoices